Raymond James & Associates Catalent, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Catalent, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 4,919 shares of CTLT stock, worth $312,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,919

Holding current value

$312,258

% of portfolio

0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$56.16 - $60.96 $276,251 - $299,862	4,919 New	4,919 $297,000
Q1 2024 Apr 22, 2024	SELL	$42.56 - $59.82 $6.17 Million - $8.67 Million	-144,910 Reduced 97.07%	4,369 $246,000
Q4 2023 Jan 16, 2024	BUY	$32.18 - $46.57 $904,451 - $1.31 Million	28,106 Added 23.19%	149,279 $6.71 Million
Q3 2023 Oct 24, 2023	SELL	$44.2 - $50.2 $2.57 Million - $2.92 Million	-58,163 Reduced 32.43%	121,173 $5.52 Million
Q2 2023 Jul 25, 2023	SELL	$31.86 - $67.26 $625,284 - $1.32 Million	-19,626 Reduced 9.86%	179,336 $7.78 Million
Q1 2023 Apr 14, 2023	BUY	$45.44 - $74.26 $164,947 - $269,563	3,630 Added 1.86%	198,962 $13.1 Million
Q4 2022 Feb 08, 2023	BUY	$41.39 - $81.0 $4.73 Million - $9.25 Million	114,218 Added 140.81%	195,332 $8.79 Million
Q3 2022 Oct 25, 2022	SELL	$72.36 - $113.1 $2.75 Million - $4.31 Million	-38,068 Reduced 31.94%	81,114 $5.87 Million
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $81,968 - $107,207	-940 Reduced 0.78%	119,182 $12.8 Million
Q1 2022 May 11, 2022	SELL	$94.19 - $124.49 $2.56 Million - $3.38 Million	-27,170 Reduced 18.45%	120,122 $13.3 Million
Q4 2021 Feb 08, 2022	BUY	$119.57 - $139.07 $1.94 Million - $2.25 Million	16,188 Added 12.35%	147,292 $18.9 Million
Q3 2021 Nov 02, 2021	SELL	$109.17 - $142.35 $1.06 Million - $1.38 Million	-9,707 Reduced 6.89%	131,104 $17.4 Million
Q2 2021 Aug 11, 2021	SELL	$100.34 - $115.69 $170,578 - $196,673	-1,700 Reduced 1.19%	140,811 $15.2 Million
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $4.27 Million - $5.27 Million	-42,042 Reduced 22.78%	142,511 $15 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $213,325 - $261,714	2,484 Added 1.36%	184,553 $19.2 Million
Q3 2020 Nov 04, 2020	BUY	$72.74 - $92.5 $1.18 Million - $1.5 Million	16,187 Added 9.76%	182,069 $15.6 Million
Q2 2020 Jul 28, 2020	BUY	$48.02 - $79.04 $67,468 - $111,051	1,405 Added 0.85%	165,882 $12.2 Million
Q1 2020 Apr 21, 2020	BUY	$36.95 - $62.95 $1.05 Million - $1.79 Million	28,429 Added 20.9%	164,477 $8.55 Million
Q4 2019 Feb 12, 2020	BUY	$47.06 - $56.64 $282 - $339	6 Added 0.0%	136,048 $7.66 Million
Q3 2019 Nov 07, 2019	SELL	$47.45 - $58.05 $1.04 Million - $1.27 Million	-21,918 Reduced 13.88%	136,042 $6.48 Million
Q2 2019 Aug 06, 2019	BUY	$39.26 - $54.21 $72,316 - $99,854	1,842 Added 1.18%	157,960 $8.56 Million
Q1 2019 May 06, 2019	SELL	$29.84 - $43.92 $4,744 - $6,983	-159 Reduced 0.1%	156,118 $6.34 Million
Q4 2018 Feb 11, 2019	BUY	$29.95 - $46.34 $242,235 - $374,797	8,088 Added 5.46%	156,277 $4.87 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $364,690 - $414,049	9,090 Added 6.53%	148,189 $6.75 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $106,325 - $116,759	2,746 Added 2.01%	139,099 $5.83 Million
Q1 2018 May 14, 2018	BUY	$39.4 - $47.39 $137,033 - $164,822	3,478 Added 2.62%	136,353 $5.6 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $712,080 - $821,940	19,106 Added 16.79%	132,875 $5.46 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $394,537 - $487,122	11,690 Added 11.45%	113,769 $4.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	102,079	102,079 $3.58 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Catalent, Inc. Transaction History